undamentalytics Newsletter
Sign in

Tandem Diabetes Care Inc income statement

In fiscal 2025, Tandem Diabetes Care Inc reported revenue of $1.01bn, up 7.9% on the year before, operating income of −$187m (a -18.5% margin) and net income of −$205m, or −$3.04 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2295073841081843624997038017489401,0151,041
Cost of revenue4233446616494168238327388380451469458
Gross profit−161527244490194261376413368490546583
Research and development9111617192129456492139170199193188
Selling, general and administrative234575798386105166205262336353390445441
Operating income−33−49−76−69−78−63−45−17−823−93−233−99−187−46
Interest expense——————————610789
Income before tax−33−63−79−72−83−73−123−25−3616−93−220−92−200−61
Income tax——00−0000−2022442
Net income−33−63−80−72−83−73−123−25−3416−95−223−96−205−63
Diluted EPS−$1.83−$3.35−$0.43−$3.13−$3.41−$1.61−$2.55−$0.42−$0.56$0.24−$1.47−$3.43−$1.47−$3.04−$0.93
Diluted shares (average)18m19m19m23m24m45m48m59m61m64m64m65m65m67m68m
EBITDA−31−46−71−64−73−56−39−11236−79−218−83−170−28

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: INSP vs TNDMTNDM vs VREXATEC vs TNDM

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Tandem Diabetes Care Inc's SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Tandem Diabetes Care Inc.